Current Ratio of BridgeBio Pharma, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
BridgeBio Pharma, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • BridgeBio Pharma, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 453%, a 9.1% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 453% +38% +9.1% 30 Sep 2025
Q2 2025 446% -23% -4.9% 30 Jun 2025
Q1 2025 427% -28% -6.2% 31 Mar 2025
Q4 2024 450% +1.3% +0.28% 31 Dec 2024
Q3 2024 415% -73% -15% 30 Sep 2024
Q2 2024 469% -18% -3.6% 30 Jun 2024
Q1 2024 455% -71% -13% 31 Mar 2024
Q4 2023 449% -103% -19% 31 Dec 2023
Q3 2023 489% -116% -19% 30 Sep 2023
Q2 2023 487% -148% -23% 30 Jun 2023
Q1 2023 526% -151% -22% 31 Mar 2023
Q4 2022 552% -188% -25% 31 Dec 2022
Q3 2022 605% -145% -19% 30 Sep 2022
Q2 2022 634% -181% -22% 30 Jun 2022
Q1 2022 677% -214% -24% 31 Mar 2022
Q4 2021 740% -226% -23% 31 Dec 2021
Q3 2021 750% -306% -29% 30 Sep 2021
Q2 2021 815% -315% -28% 30 Jun 2021
Q1 2021 891% 31 Mar 2021
Q4 2020 965% 31 Dec 2020
Q3 2020 1056% 30 Sep 2020
Q2 2020 1130% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.